B. Douglas Smith
- Hematology top 0.1%
- Molecular Biology top 2%
- Genetics top 0.5%
- Oncology top 2%
- Public Health, Environmental and Occupational Health top 2%
- Co-authors
- Mark J. LevisDonald SmallJudith E. KarpRichard J. JonesWilliam MatsuiKathleen M. MurphyKarin D. BergHagop M. Kantarjian
- Topics
- Acute Myeloid Leukemia Research (95 papers)Chronic Myeloid Leukemia Treatments (41 papers)Chronic Lymphocytic Leukemia Research (32 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- United StatesGermanyItaly
In The Last Decade
B. Douglas Smith
166 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Hematology 4.2k
- Molecular Biology 2.8k
- Genetics 1.5k
- Oncology 1.3k
- Public Health, Environmental and Occupational Health 947
Countries citing papers authored by B. Douglas Smith
This map shows the geographic impact of B. Douglas Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Douglas Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Douglas Smith more than expected).
Fields of papers citing papers by B. Douglas Smith
This network shows the impact of papers produced by B. Douglas Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Douglas Smith. The network helps show where B. Douglas Smith may publish in the future.
Co-authorship network of co-authors of B. Douglas Smith
This figure shows the co-authorship network connecting the top 25 collaborators of B. Douglas Smith. A scholar is included among the top collaborators of B. Douglas Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Douglas Smith. B. Douglas Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 8 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 10 | |
| 9 | 18 | |
| 10 | 38 | |
| 11 | 12 | |
| 12 | 74 | |
| 13 | 38 | |
| 14 | 23 | |
| 15 | 43 | |
| 16 | 77 | |
| 17 | 43 | |
| 18 | 35 | |
| 19 | 7 | |
| 20 | The novel telomerase inhibitor GRN163L targets drug-resistant cancer stem cells in multiple myeloma | 1 |
About B. Douglas Smith
B. Douglas Smith is a scholar working on Hematology, Genetics and Oncology, having authored 171 papers that have together received 6.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (95 papers), Chronic Myeloid Leukemia Treatments (41 papers) and Chronic Lymphocytic Leukemia Research (32 papers). The work is most often cited by research in Hematology (4.2k citations), Genetics (1.5k citations) and Oncology (1.3k citations). B. Douglas Smith has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Mark J. Levis, Donald Small, Judith E. Karp, Richard J. Jones, William Matsui, Kathleen M. Murphy, Karin D. Berg, Hagop M. Kantarjian, Robert A. Brodsky and Scott H. Kaufmann. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.